Common Contracts

5 similar Convertible Security Agreement contracts by Psyence Biomedical Ltd., Klotho Neurosciences, Inc.

FORM OF CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 4, 2025
Convertible Security Agreement • December 10th, 2024 • Klotho Neurosciences, Inc. • Biological products, (no disgnostic substances) • Delaware

THIS CONVERTIBLE PROMISSORY NOTE is a duly authorized and validly issued Convertible Promissory Note of Klotho Neurosciences, Inc., a Delaware corporation (the “Company”) designated as its Convertible Note due December 4, 2025 (this “Note”).

SENIOR SECURED CONVERTIBLE NOTE
Convertible Security Agreement • July 23rd, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due July 15th, 2027 (this “Note”).

SENIOR SECURED CONVERTIBLE NOTE DUE JUNE 14th, 2027
Convertible Security Agreement • June 20th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due January 25th, 2027 (this “Note”).

SENIOR SECURED CONVERTIBLE NOTE DUE JANUARY 25th, 2027
Convertible Security Agreement • June 6th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due January 25th, 2027 (this “Note”).

FORM OF SENIOR SECURED CONVERTIBLE NOTE
Convertible Security Agreement • January 31st, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at ________________ designated as its Convertible Note due January__, 2027 (this “Note”).